Translational Development Acquisition (TDAC) Notes Payables (2023 - 2026)

Translational Development Acquisition (TDAC) posted Notes Payables of $500000.0 for Q1 2026, up 150.0% on a QoQ basis from $200000.0 in Q4 2025.

Translational Development Acquisition (TDAC) Notes Payables (2023 - 2026) Analysis & Trends

Translational Development Acquisition's Notes Payables history runs 3 years deep, the most recent figure standing at $500000.0 for Q1 2026.

  • Quarterly Notes Payables changed N/A year-over-year to $500000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $500000.0 (changed N/A YoY) and the FY2025 annual result came in at $200000.0, changed N/A from the prior year.
  • Notes Payables was $500000.0 for Q1 2026 at Translational Development Acquisition, up from $200000.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $500000.0 in Q1 2026 and bottomed at $100000.0 in Q3 2025.
  • A 3-year average of $286875.0 and a median of $273750.0 in 2023 frame the typical range for Notes Payables.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 EQV Ventures Acquisition 480.75 Mn 480.75 Mn -
2 Agriculture & Natural Solutions Acquisition 393.29 Mn 393.29 Mn -
3 Berto Acquisition 314.56 Mn 314.35 Mn -
4 GP-Act III Acquisition 313.66 Mn 313.66 Mn -
5 Centurion Acquisition 311.65 Mn 311.65 Mn -
6 Republic Digital Acquisition 310.50 Mn 309.63 Mn -
7 Siddhi Acquisition Corp (Cayman Islands) 288.97 Mn 288.97 Mn -
8 K&F Growth Acquisition 283.42 Mn 283.42 Mn -
9 Bold Eagle Acquisition 275.29 Mn 275.29 Mn -
10 Translational Development Acquisition 186.90 Mn 186.90 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 500,000.00
Dec 31, 2025 200,000.00
Sep 30, 2025 100,000.00
Dec 31, 2023 347,500.00